These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34817226)

  • 21. Think of the Children: Evaluation of SARS-CoV-2 Rapid Antigen Test in Pediatric Population.
    González-Donapetry P; García-Clemente P; Bloise I; García-Sánchez C; Sánchez Castellano MÁ; Romero MP; Gutiérrez Arroyo A; Mingorance J; de Ceano-Vivas La Calle M; García-Rodriguez J;
    Pediatr Infect Dis J; 2021 May; 40(5):385-388. PubMed ID: 33605674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the Abbott Panbio
    Shaw JLV; Deslandes V; Smith J; Desjardins M
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115514. PubMed ID: 34418823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting.
    Osterman A; Baldauf HM; Eletreby M; Wettengel JM; Afridi SQ; Fuchs T; Holzmann E; Maier A; Döring J; Grzimek-Koschewa N; Muenchhoff M; Protzer U; Kaderali L; Keppler OT
    Med Microbiol Immunol; 2021 Feb; 210(1):65-72. PubMed ID: 33452927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a novel, rapid antigen detection test for the diagnosis of SARS-CoV-2.
    Thell R; Kallab V; Weinhappel W; Mueckstein W; Heschl L; Heschl M; Korsatko S; Toedling F; Blaschke A; Herzog T; Klicpera A; Koeller C; Haugk M; Kreil A; Spiel A; Kreuzer P; Krause R; Sebesta C; Winkler S; Laky B; Szell M
    PLoS One; 2021; 16(11):e0259527. PubMed ID: 34843505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus.
    Nordgren J; Sharma S; Olsson H; Jämtberg M; Falkeborn T; Svensson L; Hagbom M
    J Clin Virol; 2021 Jul; 140():104846. PubMed ID: 33971580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Performance of Ag-RDTs and NAAT for SARS-CoV2 Identification in Symptomatic Patients in Catalonia.
    Basile L; Guadalupe-Fernández V; Valdivia Guijarro M; Martinez Mateo A; Ciruela Navas P; Mendioroz Peña J; The Epidemiological Surveillance Network Of Catalonia
    Viruses; 2021 May; 13(5):. PubMed ID: 34068899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Panbio COVID-19 Ag Rapid Test: Which Performances are for COVID-19 Diagnosis?
    Farfour E; Amiel C; Jolly E; Zia-Chahabi S; Mazaux L; Simonin P; Berkane I; Cornily M; Pascreau T; Sars-CoV- MVOBOT
    Clin Lab; 2021 Nov; 67(11):. PubMed ID: 34758228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms.
    Linares M; Pérez-Tanoira R; Carrero A; Romanyk J; Pérez-García F; Gómez-Herruz P; Arroyo T; Cuadros J
    J Clin Virol; 2020 Dec; 133():104659. PubMed ID: 33160179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wide Real-Life Data Support Reduced Sensitivity of Antigen Tests for Omicron SARS-CoV-2 Infections.
    Piubelli C; Treggiari D; Lavezzari D; Deiana M; Dishnica K; Tosato EMS; Mazzi C; Cattaneo P; Mori A; Pomari E; Nicolini L; Leonardi M; Perandin F; Formenti F; Giorgetti A; Conti A; Capobianchi MR; Gobbi FG; Castilletti C
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limit of detection in different matrices of 19 commercially available rapid antigen tests for the detection of SARS-CoV-2.
    Cubas-Atienzar AI; Kontogianni K; Edwards T; Wooding D; Buist K; Thompson CR; Williams CT; Patterson EI; Hughes GL; Baldwin L; Escadafal C; Sacks JA; Adams ER
    Sci Rep; 2021 Sep; 11(1):18313. PubMed ID: 34526517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting.
    Sood N; Shetgiri R; Rodriguez A; Jimenez D; Treminino S; Daflos A; Simon P
    PLoS One; 2021; 16(4):e0249710. PubMed ID: 33819311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methods to evaluate the impact of SARS-CoV-2 nucleocapsid mutations on antigen detection by rapid diagnostic tests.
    Tieman BC; Kovacs S; Rodgers MA; Mohaimani A; Gregory S; Christensen D; Moore JA; Schurig-Briccio L; Hartnett J; Kar A; Leeman A; Palmer A; Rogers L; Dragoo B; Muszynski S; Noblesmith D; Gardner S; Snipe-Bushey A; Kill A; Luo X; Cherukuri S; Rae T; Marohnic CC; Cloherty GA; Muerhoff AS; Hemken PM
    Biotechniques; 2022 Sep; 73(3):136-141. PubMed ID: 36004516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Rapid Antigen Testing for SARS-CoV-2 in Remote Communities - Yukon-Kuskokwim Delta Region, Alaska, September 15, 2020-March 1, 2021.
    Hodges E; Lefferts B; Bates E; Desnoyers C; Bruden D; Bruce M; McLaughlin J
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(33):1120-1123. PubMed ID: 34411078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Panbio rapid antigen test for SARS-CoV-2 in symptomatic patients and their contacts: a multicenter study.
    Thirion-Romero I; Guerrero-Zúñiga DS; Arias-Mendoza DA; Cornejo-Juárez DDP; Meza-Meneses DP; Torres-Erazo DDS; Hernández-Gilsoul DT; Galindo-Fraga DA; Villegas-Mota DI; Sepúlveda-Delgado DJ; Ávila-Ríos DS; Becerril-Vargas DE; Fernández-Plata R; Pérez-Kawabe TM; Coeto-Cano DA; Vázquez-Pérez DJA; Kawa-Karasik DS; Reyes-Terán DG; Pérez-Padilla DJR
    Int J Infect Dis; 2021 Dec; 113():218-224. PubMed ID: 34678504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-market surveillance of six COVID-19 point-of-care tests using pre-Omicron and Omicron SARS-CoV-2 variants.
    Exner HM; Gregorchuk BSJ; Castor A-G; Crisostomo L; Kolsun K; Giesbrecht S; Dust K; Alexander DC; Bolaji A; Quill Z; Head BM; Meyers AFA; Sandstrom P; Becker MG
    Microbiol Spectr; 2024 Jul; 12(7):e0016324. PubMed ID: 38757955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease.
    Lv Y; Ma Y; Si Y; Zhu X; Zhang L; Feng H; Tian D; Liao Y; Liu T; Lu H; Ling Y
    Biosci Trends; 2021 May; 15(2):93-99. PubMed ID: 33776018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a rapid antigen detection test (Panbio™ COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a pediatric emergency department.
    Carbonell-Sahuquillo S; Lázaro-Carreño MI; Camacho J; Barrés-Fernández A; Albert E; Torres I; Bretón-Martínez JR; Martínez-Costa C; Navarro D
    J Med Virol; 2021 Dec; 93(12):6803-6807. PubMed ID: 34289136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for SARS-CoV-2 infection in asymptomatic individuals using the Panbio COVID-19 antigen rapid test (Abbott) compared with RT-PCR: a prospective cohort study.
    Winkel B; Schram E; Gremmels H; Debast S; Schuurman R; Wensing A; Bonten M; Goedhart E; Hofstra M;
    BMJ Open; 2021 Oct; 11(10):e048206. PubMed ID: 34645658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Need for a high-specificity test for confirming weakly positive result in an immunochromatographic SARS-CoV-2-specific antigen test: A case report.
    Tanimoto T; Matsumura M; Tada S; Fujita S; Ueno S; Hamai K; Omoto T; Maeda H; Nishisaka T; Ishikawa N
    J Microbiol Immunol Infect; 2021 Jun; 54(3):534-535. PubMed ID: 33309009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.